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Aim	and	objectives:	 The	 goal	 of	 this	 study	was	 to	 assess	 the	evidence	on	 the	 safety	 and	
effectiveness	 of	 NIV	 in	 children	 during	 transportation.	 Safety	 outcome	 measures	 were	
intubation	or	escalation	of	ventilation	mode	(during	and	soon	after	transport)	and	adverse	
event	 (AE)	 occurrence	 during	 transport.	 Effectiveness	 outcome	 measures	 related	 to	
improvement	in	clinical	parameters	during	transfer.	
Methods:	 A	 systematised	 review	 of	 the	 literature	 was	 conducted,	 based	 on	 searches	 of	
MEDLINE	via	PubMed,	EMBASE	(via	Scopus),	Cochrane	Central	Register	of	Controlled	Trials	
(CENTRAL),	 African	 Index	Medicus,	Web	 of	 Science	 Citation	 Index	 and	 the	World	 Health	
Organisation	 Trials	 Registry	 (ICTRP).	 Two	 reviewers	 independently	 reviewed	 all	 identified	





There	 were	 no	 randomised	 controlled	 trials,	 quasi-randomised	 controlled	 trials	 or	 non-
randomised	studies	of	intervention,	to	answer	the	research	question.	The	included	studies	




studies)	 or	 escalation	 of	 mode	 of	 ventilation	 (2/150;	 1%;	 HFNC	 study).	 In	 the	 24	 hours	
following	transfer,	63/650	(13%)	of	children	transferred	on	NIV,	were	intubated.	The	odds	of	





BVM	 in	 8/334	 (2%),	 desaturation	 episodes	 in	 9/290	 (3%),	 apnoea	 in	 11/290(4%)	 and	
administration	of	CPR	in	0/290	(0%)	cases	being	described.	There	was	insufficient	reporting	
of	change	in	vital	signs	or	clinical	condition	during	transport	for	meaningful	analysis.		
Conclusion:	 This	 study	 is	 the	 first	 systematised	 review	 indicating	 that	NIV	use	 in	 children	
during	 transport	 is	 likely	 to	 be	 safe.	 From	 the	 low-reliability	 evidence	 available,	 it	 was	
calculated	that	NIV	use	in	children	during	transport	would	result	in	a	0.4%	rate	of	intubation	
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What is the problem and why is it important? 





non-invasive	ventilation	 (NIV)	will	 be	 considered:	non-invasive	 continuous	positive	airway	
pressure	(CPAP)	and	high-flow	nasal	cannula	(HFNC)	therapy.	
Non-invasive	 ventilation	 is	 increasingly	 preferred	 to	 invasive	 positive-pressure	 ventilation	
(IPPV)	 in	 paediatric	 and	 neonatal	 hospital	 settings	 because	 of	 the	 avoidance	 of	 risks	
associated	with	intubation	and	IPPV.(1–6)	The	problem	is	that	NIV	use	in	children	in	the	pre-




What is known – in brief? 
The	majority	of	high-quality	randomised	controlled	trial	(RCT)	evidence	on	NIV	use	in	children	
comes	from	the	neonatal	intensive	care	unit	(NICU)	settings.	There	is	a	gradually	increasing	





evidence	 on	 HFNC	 use	 to	 draw	 conclusions.	 There	 is	 increasing	 evidence	 that	 newer	
modalities	of	CPAP,	using	bi-level	pressures,	may	be	more	effective	than	traditional	CPAP.	
The	major	drawbacks	of	NIV	are	related	to	two	main	categories	of	adverse	effect:	air	leaks	
and	 local	 pressure	 problems.	 See	 Chapter	 2:	 Literature	 Review,	 for	 a	 more	 detailed	
presentation	of	the	research	evidence	regarding	clinical	effectiveness	of	NIV	use	in	neonates	
and	children.	




mortality	 and	 intubation	 rates.(9,10)	 However,	 research	 on	 the	 use	 of	 NIV	 in	 children	 in	
transport	settings	is	still	sparse	and	is	the	subject	of	this	review.	
What will this study add? 























How was this study done? 






A	 detailed	 research	 question	 was	 delineated,	 with	 pre-specified	 primary	 and	 secondary	
objectives	–	see	Chapter	3:	Research	Questions,	Study	Aims	and	Objectives.	The	search	phase	
involved	a	comprehensive	systematic	search	with	the	assistance	of	a	research	librarian.	Pre-
defined	search	 terms	were	used	 to	 search	a	broad	 range	of	 relevant	databases	and	 trials	
registries.	 This	was	 followed	by	a	 selection	process	 involving	 two	 independent	 reviewers,	
reviewing	titles	for	pre-defined	inclusion	and	exclusion	criteria,	with	a	full-text	review	of	any	




How were studies assessed for quality? 
Following	 the	 selection	 process,	 it	 became	 apparent	 that	 all	 included	 studies	 were	
observational	studies.	These	were	primarily	of	cohort	type	design,	with	a	variety	of	mainly,	
retrospective	 record	 review	 and	 database	 search	 methods	 used.	 Details	 of	 study	
methodology,	as	well	as	the	scope	and	depth	of	reporting	of	outcomes,	was	variable.		
Quality	assessment	(QA)	tools	are	available	for	a	number	of	study	designs	(see	Appendix	A),	
however,	 few	 are	 suitable	 for	 comparison	 of	 retrospective,	 record	 and	 database	 review	
studies,	with	 a	moderate	 degree	 of	 variation	 in	 reporting.	 For	 this	 reason	 a	QA	 tool	was	
adapted	 for	 use	 in	 this	 study.	 The	 evolution	 of	 the	 original	 tool	 is	 described	 in	 detail	 in	
Appendix	A	 and	 the	 original	 tool	 is	 available	 in	Appendix	 B.	 The	 process	 of	 adaptation	 is	
described	in	Chapter	4:	Methodology	and	the	adapted	tool	is	presented	in	Appendix	C.	


















This	 section	 provides	 an	 overview	 of	 lung	 dynamics	 and	 respiratory	 physiology	 that	





The	 functional	 residual	 capacity	 (FRC)	 is	 the	 volume	of	 air	 left	 in	 the	 lungs	 at	 the	 end	of	
exhalation,	 and	 this	 is	where	 gas	 exchange	 takes	 place.(2)	 The	 FRC	 is	 determined	 by	 the	
balance	between	the	elastic	recoil	of	lung	tissues	and	the	outward	pull	of	the	chest	wall.	(1,2)	













air	 into	 the	 lungs.(1,2)	 In	 adults,	 the	 main	 resistance	 to	 airflow	 is	 from	 upper	 airway	
structures,	 but	 in	 children	 under	 five	 years	 of	 age,	most	 resistance	 is	 found	 in	 the	 small	
peripheral	airways.(2)	These	airways	are	considerably	smaller	than	those	of	adults	or	older	





The	 main	 work	 of	 breathing	 (WOB)	 occurs	 during	 inspiration,	 when	 intercostal	 and	
diaphragmatic	muscles	contract	to	expand	the	chest.(1)	Exhalation	is	normally	passive,	but	
may	become	active	 in	disease	states	with	 increased	resistance	 to	expiratory	airflow.(1)	 In	
infants	the	diaphragm	contains	fewer	Type	1	muscle	fibres	than	in	adults,	and	this	makes	it	
more	susceptible	to	fatigue.(1)	





























(Type	 1)	 with	 low	 Pa02	 and	 normal-low	 PaC02,	 whereas	 Type	 2	 ARF	 is	 characterised	 by	
hypoventilation	with	high	PaC02,	with	or	without	low	Pa02.	Patients	in	whom	the	respiratory	
muscles	start	 to	 fail	 can	 transition	 from	Type	1	 to	Type	2	ARF.(20)	Provision	of	additional	
fractional	 inspired	oxygen	 (Fi02)	will	only	assist	with	hypoxia.	Reducing	 the	arterial	partial	













mechanism	 of	 action,	methods	 of	 generation	 and	 settings	 used	 for	 CPAP	 and	HFNC.	 The	
section	 ends	 with	 a	 consideration	 of	 the	 literature	 on	 matters	 such	 as	 NIV	 interfaces,	
synchronisation	and	adverse	effects.	
Evolution	of	mechanical	ventilation	
Whilst	 it	was	 recognised	 as	 far	 back	 as	 the	 sixteenth	 century	 that	 application	 of	 positive	
pressure	through	the	trachea	could	be	used	for	resuscitation	(see	Figure	2),	a	lack	of	suitable	
materials	and	technology	meant	that	any	form	of	assisted	ventilation	was	slow	to	evolve.(21)	
Initial	 attempts	at	mechanical	 ventilation	 centred	around	 the	use	of	negative	pressure	 to	
expand	the	patient’s	lungs	externally;	as	will	be	described,	there	has	been	a	cycle	from	initial	
















































early	days	of	 IPPV,	 it	has	been	 increasingly	recognised	that	direct	 transmission	of	positive	


































































































































entity(1,2);	 for	 the	 purposes	 of	 this	 review,	 CPAP	 (and	 its	 derivatives)	will	 be	 considered	
separately	 from	HFNC	oxygen	 therapy.	 It	 should	 be	 noted	 that	 a	 recurrent	 problem	with	
evaluating	 the	 literature	 on	 NIV	 is	 that	 studies	 in	 this	 domain	 use	 a	 variety	 of	 devices,	




Continuous	 positive	 airway	 pressure	 involves	 the	 provision	 of	 a	 set	 background	 level	 of	
positive	pressure	to	the	patient’s	airways	throughout	the	respiratory	cycle.	Using	standard	















• Expiratory	flow	valve	–	a	valve	 in	the	expiratory	 limb	of	a	mechanical	ventilator	 is	
adjusted	 to	 impede	 expiratory	 gas	 flow	 resulting	 in	 positive	 pressure	 to	 be	






















	 0cm	 2cm	 4cm	 6cm	 8cm	
Respiratory	
rate	
70	±	12	 50	±	15	 55	±	12	 52	±	17	 45	±	18	
EELV	 0	 38	±	25	 110	±	46	 135	±	49	 210	±	37	
Tidal	volume	 99	 104	±	10	 110	+18	 125	±	20	 143	±	24	
Phase	angle	 76	±21	 63	±	25	 54	±	19	 36	±	27	 30	±	15	







CPAP	pressure	of	12mmHg	 (16cmH2O)	was	used	 (38),	but	 it	 now	seems	 to	have	become	






Evidence	 suggests	 that	 higher	 CPAP	 pressures	 lead	 to	 improvement	 in	 a	 range	 of	 lung	



















gases	 is	 postulated	 to	 improve	 gas	 flow	 dynamics	 as	 well	 as	 reduce	 metabolic	 energy	




A	 blend	 of	 oxygen	 and	 air	 is	 passed	 through	 a	 heating	 and	 humidifying	 unit	 and	 then	














expiratory	 efforts.	 HFNC	 provides	 adequate	 flow	 rates	 to	 match	 inspiratory	 flow	 and	 thus	






























Vapotherm	 34.0	 99	 34.3	 81.2	







that	 some	authorities	 advocate	 a	 flow	 rate	per	minute	 (L/min)(51),	whilst	 others	 suggest	
weight-based	flow	rates	(L/kg/min).(52)	Schibler	et	al.	suggest	that	the	HFNC	flow	rate	should	























Studies	 (lab-bench,	 animal	 and	 in	 vivo)	 have	 attempted	 to	measure	 the	 airway	 pressure	
generated	by	HFNC	(44),	but	with	conflicting	results,	as	in	the	case	of	two	studies	in	preterm	
babies:	 the	 one	 reported	 distending	 pressures	 of	 up	 to	 8cm	 H20	 with	 as	 little	 as	 1-
2.5L/min(56),	and	the	other,	airway	pressures	of	 less	than	6cm	H2O	with	6L/min.(57)	The	























Interfaces	 that	 cover	 the	mouth	 are	 tolerated	better	 by	 older	 children	 and	 eliminate	 the	
problem	 of	 mouth-leak.	 However,	 they	 greatly	 compromise	 the	 ability	 to	 feed	 and	































































an	 important	 consideration	 for	 BLCPAP	 modes.	 The	 method	 used	 for	 synchronisation	
depends	on	the	BLCPAP	device	being	used,	but	it	usually	involves	pressure	or	flow	sensors.	
Synchronisation	is	relatively	easily	accomplished	in	adults	and	older	children	because	tight-











Neurally-adjusted	 ventilatory	 assistance	 (NAVA)	 is	 a	 promising	 new	 synchronisation	
technique	which	uses	electromyography	(EMG)	signals	from	diaphragmatic	muscles	to	allow	
adaptation	to	the	phase	of	respiration	and	degree	of	work	of	breathing.(1)	The	NAVA	EMG	




by	 covering	 the	 nose,	 mouth	 or	 face	 with	 NIV	 interfaces,	 which	 may	 need	 to	 be	 tightly	
applied.	 Small	 children	 are	 particularly	 likely	 to	 have	 increased	 upset	 and	 struggling	
associated	with	NIV,	and	this	may	interfere	with	respiratory	support.	There	is	no	agreement	
on	 the	 need	 for	 sedation	during	NIV(62).	 There	 are,	 however,	 concerns	 that	 any	 form	of	
sedation	may	 adversely	 affect	 the	 patient’s	 ability	 to	 self-ventilate.(53,62)	 Longrois	 et	 al.	
describe	the	use	of	a	variety	of	drugs,	including	midazolam,	dexmedetomidine,	propofol	and	






























































Historically,	 there	 are	 reports	 of	 neonatal	 CPAP	 being	 associated	 with	 cranial	 vault	
























































Clinical Effectiveness of NIV in Children 
Systematic	 review	 (with	 or	 without	 meta-analysis)	 is	 relied	 upon	 in	 this	 section,	 which	






been	 conducted	 in	 the	NICU	environment.	Unfortunately,	 research	 evidence	of	 the	 same	










(with	 meta-analyses)	 on	 clinical	 effectiveness	 of	 NIV	 in	 NICU	 settings:	 Subramaniam	 et	
al.(41);	 Ferguson	et	 al.(90);	Wilkinson	et	 al.(45);	 Lemyre	et	 al.(91)	 and	Kotecha	et	 al.(67).	
Evidence	from	the	paediatric	realm	will	be	limited	to	summarising	four	recent	reviews,	one	
of	 which	 evaluates	 literature	 on	 NIV	 in	 Paediatric	 Acute	 Respiratory	 Distress	 Syndrome	












box	oxygen,	 there	 is	 low	quality	 evidence	 that	CPAP	 reduces	 the	 incidence	of	 extubation	













Continuous	 positive	 airways	 pressure,	 compared	 with	 assisted	 ventilation,	 was	 found	 to	
reduce	CLD	at	28	weeks	GA	in	one	study	(610	infants)	that	reported	no	sustained	reduction	
beyond	 that	 age.(42)	However,	meta-analysis	 of	 three	 trials	 (2150)	 found	moderate-level	
evidence	of	reduction	in	the	incidence	of	CLD	at	36	weeks	GA	(NNTB	25).(41)	





of	 pneumothorax.(41)	 This	 result	 was	 heavily	 influenced	 by	 one	 study	 in	 which	 infants	





















































































































































































































included	 10	 studies	 evaluating	 early	 NIPPV	 versus	 early	 CPAP	 in	 preterm	 infants,	 while	

















and	 (2)	 infants	 requiring	 respiratory	 support	 following	 a	 period	 of	 IPPV	 (934	 infants,	 six	


















































































































The	 Paediatric	 Acute	 Lung	 Injury	 Consensus	 Conference	 (PALICC)	 published	
recommendations	 in	 2015	 on	 the	 use	 of	 NIV	 for	 PARDS	 based	 on	 a	 review	 of	 the	
literature.(92)	Due	to	a	lack	of	RCT	evidence,	they	included	a	broad	range	of	study	types	and	





































acute-care	 setting	 with	 continuous	 monitoring	 and	 where	
invasive	ventilation	is	also	available.	
7.2.1	We	recommend	that,	although	non-invasive,	NPPV	should	




The	 efficacy	 of	 NPPV	 is	 associated	 with	 a	 good	 patient-
ventilator	 interface.	Appropriately	 fitting	masks	will	 improve	
tolerance	of	NPPV	therapy.	Facial	or	oronasal	masks	provide	
superior	 support	 to	 nasal	 and	 helmet	 interfaces	 in	 children	







of	 support	during	 inspiration	will	 provide	a	 superior	 level	 of	
support	than	continuous	positive	pressure	alone.	
7.3.6	 To	 reduce	 inspiratory	 muscle	 effort	 and	 improve	
oxygenation,	 we	 recommend	 non-invasive	 pressure	 support	
ventilation	 combined	with	 positive	 end-expiratory	 pressure	 in	
patients	with	PARDS.	Continuous	positive	airway	pressure	alone	










and	 included	only	one	pilot	 study	 (51)	 in	which	19	patients	were	 randomised	 to	HFNC	or	




of	 oxygen	 therapy	 or	 length	 of	 hospital	 stay.	 The	 second	 Cochrane	 review,	 of	 HFNC	 for	
respiratory	 support	 in	 children	 (excluding	 bronchiolitis),	 found	 no	 studies	 meeting	 their	
inclusion	criteria.(94)	




emergency	 departments.(95)	 This	 review	 did	 not	 define	 outcome	 measures,	 nor	 did	 it	
attempt	to	assess	the	risk	of	bias	of	included	studies	or	evaluate	the	strength	of	evidence	for	











The	critical-care	 transport	environment	necessitates	 some	paradoxical	 requirements	 from	
























variety	 of	 settings,	 including	 paediatric	wards	 and	 adult	 ICUs.(103)	 During	 the	 1990s	 this	
situation	was	 increasingly	 recognised	as	unacceptable	as	 there	was	mounting	evidence	of	
improved	outcomes	for	critically	ill	children	managed	in	designated	PICUs.(104,105)	
Subsequently,	 there	has	been	a	major	reconfiguration	of	critical-care	services	 for	children	
and	 neonates	 in	 developed	 countries	 over	 the	 past	 25	 years,	 which	 has	 necessitated	





















and	 contained	 significantly	 more	 cardiac	 and	 neurological	 cases	 compared	 to	 specialist	
transfers.(111)	
In	 a	 second	 study	 of	 UK	 PICU	 transfer	 data,	 complete	 data	was	 available	 on	 the	 type	 of	
retrieval	 team	for	16875	 (96%)	of	17,649	transfers	 from	other	hospitals.	Of	 these,	13,729	
(81%)	 were	 done	 by	 specialist	 RTs	 and	 3146	 (19%)	 by	 non-specialists	 RTs.	 Multivariate	
analysis,	 after	 adjustment	 for	 factors	 including	 age,	 sex	 and	 paediatric	 index	 of	mortality	















The	 transport	 situation	 is	 distinct	 from	 facility-based	 healthcare	 because	 of	 significant	
differences	 such	 as	 environmental	 constraints,	 staff	 numbers,	 skill-mix	 and	 nature	 of	 the	
work.(9,25,102)	 Some	 of	 the	 most	 relevant	 technical	 limitations	 relating	 to	 NIV	 in	 the	
transport	setting	will	be	discussed	next.	
Medical	gas	supply	
Non-invasive	 ventilation	 is	mechanically	 reliant	 on	 the	 primary	 gas	 supply	 and	 therefore	
consumes	a	high	volume	of	medical	gas.	Neither	piped	medical	gases	nor	a	concentration	of	
oxygen	from	the	atmosphere	are	 feasible	 in	 the	transport	setting.	This	means	reliance	on	
compressed	gases	in	cylinders:	oxygen	cylinders	are	widely	available,	but	compressed	air	is	
less	widely	available	in	the	transport	setting.	Administration	of	high	Fi02	is	potentially	harmful	






essential,	 ideally	 all	 equipment	 should	 have	 several	 hours	 of	 battery-life.(25,102)	Whilst	
transport	ventilators	have	batteries,	many	standalone	NIV	devices,	such	as	HFNC	machines	
do	not	have	battery-power	capability.	Power	supply	and	recharging	options	are	very	limited	




of	 inspired	 gases	 can	 be	 problematic	 when	 ventilation	 devices	 are	 not	 plugged	 in.	 One	
commercially	available	exception	is	the	Neo-Pod	‘T’	heating	device,	coupled	with	a	Lavabed	











































Non-invasive	 ventilation	 has	 become	 increasingly	 popular	 in	 critical	 care	 and	 emergency	
settings	over	 the	past	15-20	years,	but	 its	availability	 in	 the	pre-hospital	 setting	has	been	








National	 Institute	 of	 Health	 Research	 (NIHR)	 recently	 undertook	 an	 independent	 Health	


























































o blood	 gas	 results	 (arterial,	 capillary	 or	 venous)	 suggestive	 of	 respiratory	
compromise.	
• Inter-facility	 transport	 (IFT)	 involves	 movement	 of	 patients	 between	 healthcare	
facilities	by	trained	pre-hospital	providers.	










• Non-invasive	 ventilation	 (NIV)	 is	 any	 modality	 of	 assisted	 ventilation	 for	
spontaneously	 breathing	 patients	 that	 does	 not	 require	 the	 presence	 of	 an	
indwelling	 ETT,	 SGA	 device	 or	 tracheostomy	 tube.	 Studies	 of	 external	 negative	
pressure	devices	will	be	excluded.	NIV	will	be	considered	 in	 two	separate	groups:	
continuous	 positive	 airway	 pressure	 (CPAP)	 and	 high-flow	 nasal	 cannula	 (HFNC)	
therapy.	(For	details	of	the	definitions	used	in	this	study,	see	Table	2.)	
																																								 																				 	








The	 primary	 outcome	measures	 related	 to	 the	 safety	 of	 NIV	 in	 preventing	 escalation	 of	
respiratory	 support	 and	 lack	 of	 adverse	 events	 during	 transport.	 Secondary	 outcome	































































In	 order	 to	 be	 eligible	 for	 inclusion,	 the	 studies	 needed	 to	 report	 on	 at	 least	 one	 of	 the	























































Non-invasive	 ventilation,	 high-flow	 nasal	 cannula,	 nasal	 continuous	 positive	 airway	





















The	 systematic	 search	 was	 conducted	 between	 15-23	 March	 2017.	 As	 an	 example,	 the	









The	 list	 of	 identified	 titles,	 some	 accompanied	 by	 abstracts,	 was	 reviewed	 by	 two	

























QA	 tool	 was	 assessed	 using	 agreement	 Intra-Class	 Correlation	 (ICC)	 with	 a	 two-way	
underlying	ANOVA	model.	
Intubation	within	24-hours	






Quality Assessment of Studies 
Quality	Assessment	Hierarchy	
The	 following	 published	 QA	 tools	 were	 identified	 as	 appropriate	 for	 use	 with	 the	 study	
designs	listed:	














The	 generic	 tool	 was	 adapted	 from	 the	 18-item	 Moga	 Quality	 Appraisal	 Tool	 for	 Case-
series(124)	(see	Appendix	B).	The	authors	are	clear	 in	their	discussion	and	conclusion	that	





study	 design,	 participant	 selection,	 study	 procedures	 and	 completeness	 of	 reporting	 (see	





Examples	 of	 deleted	 criteria	 include:	 ‘Were	 the	 case	 series	 collected	 in	 more	 than	 one	
centre?’	And	‘Did	patients	enter	the	study	at	a	similar	point	in	the	disease?’	An	example	of	
modified	 criterion	 is:	 ‘Did	 the	 authors	 describe	 the	 intervention?’	 This	was	 replaced	with	
three	criteria:	 ‘Was	 the	method	of	NIV	generation	clearly	described	 in	 the	study?	 (Device	
details,	 manufacturer,	 model	 etc.)’;	 ‘Was	 the	 type	 of	 NIV	 interface	 used	 described?	
(nasal/nasopharyngeal	prongs,	mask,	helmet	etc.)’	and	‘Is	there	adequate	description	of	the	
NIV	protocols	used?	 (indications,	contraindications,	pressure/flow	etc.)’	Repetitive	criteria	





























No	RCT,	QRCT	or	NRSI	 studies	 addressing	 the	 research	question	were	 found.	All	 included	
studies	 are	 observation	 in	 design:	 seven	 used	 a	 retrospective	 record	 review	


















































































































Study	ID	 BC	rating	(%)	 BR	rating	(%)	 Consensus	scores	(%)	 Decision	
BAIRD-2009	 52.5	 62.0	 55.0	 Include	
BOMONT-2006	 72.5	 60.0	 57.5	 Include	
BOYLE-2014	 17.5	 10.0	 12.5	 Exclude	
FLEMING-2012	 82.5	 70.0	 82.5	 Include	
JANI-2014	 92.5	 87.5	 92.5	 Include	
KAPADIA-2012	 31.0	 35.0	 30.0	 Exclude	
MILLAN-2017	 77.5	 75.0	 77.5	 Include	
MURRAY-2008	 80.0	 72.5	 77.5	 Include	
OFOEGBU-2006	 47.5	 35.0	 40.0	 Exclude	
RESNICK-2010	 72.5	 67.5	 72.5	 Include	
SCHLAPBACH-2014	 82.5	 70.0	 75.0	 Include	












one	month	 prior	 to	 transport.	 Exclusion	 criteria	 included	 cardiopulmonary	 arrest,	 shock,	
head/neck	trauma	and	those	with	ARF	unable	to	protect	the	airway.	It	is	interesting	to	note	
that	 patients	with	 chronic	 respiratory	 failure	 and	weak	or	 absent	 cough	were	 eligible	 for	
inclusion.	
This	 study	 reported	 on	 two	 modes	 of	 NIV	 during	 transport:	 CPAP	 and	 BiPAP.	 NIV	 was	







conducted	by	 a	doctor-nurse	 team	 (n=84),	 and	 ‘nurse-led’	 transfers	 (n=16).	 Inclusion	and	




Fleming	 et	 al.(127)	 identified	 51	 infants	 with	 suspected	 bronchiolitis	 from	 a	 neonatal	
transport	database.	These	infants	were	managed	with	CPAP	during	retrieval	in	their	defined	
study	period.	Infants	who	were	transferred	on	oxygen	alone	or	IPPV	were	excluded,	as	were	
those	 with	 respiratory	 failure	 from	 causes	 other	 than	 bronchiolitis.	 Continuous	 positive	
airway	pressure	during	transport	was	delivered	using	a	Stephan	Reanimator	120	Ventilator	
(Stephan	GMBH,	Gackenbach,	Germany).	
Jani	 et	 al.(128)	 reviewed	 an	 electronic	 database	 of	 transfers	 performed	 by	 a	 regional	
neonatal	transfer	team	to	identify	50	infants,	aged	less	than	32	weeks	GA	and	less	than	72	











and	 108	 (37%)	 on	 NIV.	 The	 results	 of	 this	 study	 are	 reported	 in	 three	 separate	 periods,	
reflecting	the	evolution	of	a	local	NIV	protocol.	The	protocol	was	supposed	to	be	available	in	
the	supplementary	materials	for	this	article,	but	the	materials	were	not	found	at	the	journal	
website.	 The	 study	 author	 was	 contacted	 and	 provided	 the	 protocol	 and	 additional	
information	 by	 email.	 Some	 of	 the	 information	 provided	 in	 this	 section	 comes	 from	 this	
personal	 communication	with	 Dr	 Nuria	Millan.	 Non-invasive	 ventilation	 in	 this	 study	was	
provided	by:	the	Oxylog	3000	(Draeger	Medical,	Luebeck,	Germany)	for	38	patients	weighing	
over	10kg;	the	Crossvent	2+	(Bio-Med	Devices,	Guilford,	Connecticut,	US)	for	67	transfers	in	
patients	 weighing	 less	 than	 10kg	 and	 three	 children	 were	 transported	 using	 their	 home	
ventilators	[personal	communication	from	Dr	Nuria	Millan].		
Indications	 for	 NIV	were	 Type	 1	 or	 Type	 2	 ARF	with	 definitions	 and	 criteria	 given	 in	 the	
protocol.	 General	 contraindications	 for	 NIV	 were:	 undrained	 pneumothorax;	 bullous	
pneumopathy;	vocal	cord	paralysis;	hemodynamic	instability;	Glasgow	Coma	Scale	less	than	
or	equal	 to	12;	or	progressive	decrease;	active	gastrointestinal	bleeding,	 recent	gastric	or	
esophageal	 surgery,	 vomiting	 or	 bowel	 obstruction	 and	 patients	 with	 sinus	 infection,	
pneumoencephalus	 on	 CT	 scan	 or	 facial	 trauma.	 Specific	 contraindications	 for	 NIV	 in	
transport	were	patients	with:	NIV	in	the	emergency	room;	without	appropriate	improvement	




body)	 and	 poorly	 cooperation	 despite	 sedation	 [personal	 communication	 from	 Dr	 Nuria	
Millan].		
Murray	 et	 al.(7)	 searched	 a	 computer	 database	 of	 all	 neonatal	 transports	 done	 by	 a	
specialised	 neonatal	 transfer	 team	 where	 CPAP	 was	 used.	 They	 identified	 220	 patients	
treated	with	CPAP,	of	whom	13	were	intubated	prior	to	transport.	The	remaining	207	infants	
were	transported	on	CPAP.	Four	of	these	were	considered	CPAP	failures,	on	the	basis	of	a	






















the	 in-house	 RT	 were	 included	 –	 any	 transfers	 conducted	 by	 other	 RTs	 were	 excluded	
(number	not	provided);	no	other	exclusion	criteria	were	 specified.	The	authors	 state	 that	
HFNC	 was	 delivered	 using	 a	 heated	 humidifier	 device	 (Fisher	 &	 Paykel	 Healthcare	 Ltd.,	
Auckland,	New	Zealand).	During	the	first	four-year	study	period,	there	were	small	numbers	























of	Diseases	 in	Childhood,	 Fetal	 and	Neonatal	 Edition.(134)	All	 four	excluded	 studies	were	
reported	in	less	than	700	words	and	with	three	references	or	less.	Upon	QA	evaluation	of	the	
study	 reports,	 they	 scored	 below	 inclusion	 level,	 primarily	 because	 they	 contained	
insufficient	information	for	analysis	in	this	review.	
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Intubation	 post-transfer	 is	 reported	 in	 seven	 studies	 (n=	 744):	 six	 CPAP	 studies	 (n=594)	
(7,8,125,127–129)	and	one	HFNC	study	(n=150)(7,8,125,127–130).	Overall,	97/744	(13%)	of	
children	were	intubated	during	the	varying	follow-up	periods	of	these	studies.	Not	all	studies	




the	 overall	 number	 intubated	 and	 those	 intubated	 within	 two	 hours	 and	 2-12	 hours	 of	















The	 reporting	 of	 AEs	 during	 transport	was	 incomplete	 and	 variable	 amongst	 the	 studies.	
Adverse	 events	 during	 transport	 were	 not	 described	 in	 the	 HFNC	 transfer	 study.(130)	

















the	purposes	of	 this	 study,	 in	 cases	where	 authors	 used	 general	 descriptions	 such	 as	 ‘no	
adverse	events	experienced’,	it	was	assumed	that	these	events	did	not	occur.	
Results	for	AEs	during	transport	were	collated	only	where	at	 least	four	of	the	seven	CPAP	
studies	 reported	 on	 the	 AE,	 either	 directly	 or	 in	 a	 manner	 from	 which	 the	 presence	 or	
absence	of	the	AE	could	be	deduced.	The	specific	adverse	events	that	were	reported	during	
transport	 include	 BVM	 8/334(2%),	 desaturation	 9/290(3%)	 and	 apnoea	 11/290(4%)	 (see	
Table	16).	
Two	 studies	 reported	greater	details	of	 specific	 adverse	events	during	 transport.	Baird	 et	
al.(125)	state:	‘Airway	suctioning	and/or	use	of	bag–valve–mask	ventilation	during	transport	







occurred	 during	 doctor-nurse	 team	 transfers:	 one	 apnoea,	 one	 desaturation	 and	 one	







Two	 studies	 reported	 on	 HR	 measurements	 at	 different	 time-points	 during	 the	 transfer	
process.	Baird	et	al.(125)	report	on	vital	signs	from	31	NIV	transport.	They	found	no	change	






















Jani	 et	 al.(128)	 had	 measures	 of	 Fi02	 recorded	 at	 three	 time	 points:	 at	 first	 look,	 at	
stabilisation	 and	 at	 admission	 to	 the	 receiving	 facility.	 These	 measures	 were	 compared	



















145/167	patients	 successfully	 transferred	on	CPAP,	 they	 found	 significantly	 higher	 Fi02	 at	




































Some	 degree	 of	 information	 regarding	 the	 settings	 used	 for	 NIV	 during	 transport	 was	
reported	 in	 seven	 studies	 (see	 Table	 17).	 (7,8,125,127–130)	 The	 CPAP	 pressure	 varied	
between	5-10	cmH2O	and	HFNC	was	given	as	2L/kg/min,	with	BLPAP	values	varying.	There	

























Bomont-2006		 CPAP	(100)	 Ventilator	 Bi-nasal	prongs	(Argyle)	 0/100	(0%)	 ND	
Fleming-2012		 CPAP	(51)	 Ventilator	 Bi-nasal	prongs	(Hudson)	 34/51	(67%)	 7cm	(1.2)1	















Murray-2008		 CPAP	(207)	 Ventilator	 Bi-nasal	prongs	(Hudson)	 133/220	(60%)9	 7	(5-10)2	
Resnick-2010		 CPAP	(167)	 Ventilator	 Bi-nasal	prongs	(Hudson)	 167/167	(100%)	 5-6cm10	























two	of	 these	studies	 there	was	no	option	 in	 terms	of	RT	commencing	of	NIV/non-NIV	 for	
transport:	in	the	Bomont	et	al.(126)	study,	cases	were	all	identified	by	the	fact	that	they	were	
on	CPAP	at	the	time	of	referral,	and	in	the	Resnick	et	al.(8)	study,	only	cases	where	the	RT	






































































































































5).(7,125–129)	Only	 two	 specifically	mention	 the	paramedic	 component:	Baird	et	 al.(125)	
report	that	55%	of	transports	were	done	by	a	team	of	two	paramedics,	and	Jani	et	al.(128)	
describe	paramedics	as	being	part	of	the	PICU	transport	team.	














median)	 ranging	 between	 18-150	 km.	 Duration	 of	 transport	 was	 reported	 in	 six	 studies	































































































To	 the	 authors’	 knowledge,	 this	 is	 the	 first	 systematised	 review	 of	 the	 literature	 on	 NIV	
transport	 in	 children.	 Systematic	 review	 data	 exists	 for	 NIV	 use	 in	 hospitalised	 children,	
particularly	for	those	in	intensive	care	settings;	however,	no	such	review	data	exists	for	NIV	
use	in	children	during	transport.	
This	 review	 included	 eight	 observational	 studies	 of	 NIV	 use	 in	 children	 during	 transport:	
seven	studies	 (n=708)	evaluated	CPAP	during	transfer	and	one	study	 (n=150)	reported	on	
HFNC	use	during	 transport.	There	were	no	RCT,	QRCT	or	NRSI	 identified,	and	 thus	all	 the	
evidence	reported	in	this	review	is	based	on	low-reliability	research.	
Intubation or Escalation of Ventilation during 
Transfer 
Transportation	of	children	on	NIV	appears	 safe,	with	only	3/858	 (0.4%)	patients	 requiring	
either	 intubation	(1/708;	0.1%;	CPAP	studies)	or	escalation	of	mode	of	ventilation	(2/150;	
1%;	HFNC	study)	during	NIV	transfer.	High-quality	trial	data	for	children	is	not	available	for	
comparison,	 but	 these	 findings	 are	 in	 keeping	with	 reported	 rates	 of	 intubation	 of	 adult	
patients	on	NIV	during	transportation	0-3.2%.(117,135)	









Intubation or Escalation of Ventilation after 
Transfer 













of	 intubation	 in	 the	 24	hours	 after	 transport.	 As	HFNC	 is	 a	 newer,	 less	 ‘tried	 and	 tested’	
therapy,	 it	may	be	 that	HFNC	was	used	 in	 less	 sick	children.	Whereas	children	with	more	
obvious	 respiratory	 difficulty	 may	 have	 been	 started	 on	 CPAP	 prior	 to	 transfer,	 and	
subsequently	the	sicker	CPAP	group,	required	a	higher	rate	of	intubation.	A	lack	of	reporting	




most	 studies	 either	 specified	 the	 number	 of	 patients	 intubated	 within	 24	 hours,	 or	 this	
number	could	be	calculated	from	the	data	given.	For	some	studies,	the	reported	end	point	
was	at	24	hours;	other	studies	continued	their	follow-up	beyond	24	hours	or	did	not	specify	
the	duration	of	 follow-up.	This	variation	 in	 follow-up	cut-off	makes	 it	difficult	 to	compare	






discerned,	 this	adds	to	 the	difficulty	 in	comparing	 intubation	and	AE	rates	between	these	
studies.	Hence,	it	is	also	problematic	to	generalise	the	findings	of	this	review.	
In	 this	 area	 of	 research,	 intubation	 following	 transfer	 is	 generally	 being	 used	 as	 a	 proxy	















of	 back-up	 equipment,	 skills	 and	 facilities	 should	 anything	 go	 wrong.	 Therefore,	 not	
intubating	prior	to	(or	during)	transfer	is	likely	to	be	in	the	patient’s	best	interests,	as	long	as	









and	 administration	 of	 CPR	 in	 0/290	 (0%)	 cases	 being	 described.	 These	 results	 were	
extrapolated	 from	 two	 studies	 (125,126)	 that	 reported	 these	AEs	 directly	 combined	with	
studies	that	made	statement	to	the	effect	of	no	AEs	having	occurred	during	transport.	
These	 findings	 are	 in	 keeping	with	 the	 4%	preventable	 physiological	 AE	 rate	 reported	 by	
Britto	et	al.	for	transfers	done	by	a	specialised	paediatric	RT.(138)	But	this	rate	is	well	below	
the	 reported	 range	 of	 33-75%	 AEs	 during	 emergency	 transport	 of	 adults	 and	





Evaluating	evidence	on	 this	 topic	was	 significantly	hampered	by	 the	 fact	 that	 few	studies	
specifically	mentioned,	or	gave	 sufficient	details	of,	AEs	experienced	during	 the	 transport	
phase.	This	was	true	even	of	the	one	prospective	observational	study	(129)	which,	similar	to	




that	 might	 reasonably	 be	 expected	 to	 occur.	 This	 includes	 episodes	 of	 desaturation,	
bradycardia,	 apnoea	or	 the	need	 for	 interventions	 such	as	 suctioning,	BVM	ventilation	or	
CPR.	This	level	of	detail	was	reported	only	in	two	studies	(125,126),	but	the	wording	was	still	
unclear	 and	 containing	 statements	 such	as,	 ‘Airway	 suctioning	and/or	use	of	BVM	during	
transport	 were	 performed	 on	 8/31	 transports	 because	 of	 episodes	 of	 desaturation,	
occasionally	with	bradycardia’.(125)	
Lack	of	details	available	in	database	information	
The	 ill-defined	 reporting	 of	 AEs	 is	 likely	 to	 be	 related	 to	 a	 paucity	 of	 AE	 details	 in	 the	
databases	 being	 used	 to	 inform	 the	 studies.	 This	 lack	 of	 specific	 information	 is	 a	 serious	
limitation	 in	 the	 interpretation	 of	 the	 occurrence	 of	 AEs	 and,	 hence,	 of	 safety	 during	
transport	of	children	on	NIV.	As	such,	one	of	the	recommendations	stemming	from	this	study	
is	 the	setting	up	detailed	registries	 for	patients	 transferred	on	NIV.	Alternatively,	where	a	
current	transport	database	exists,	the	recommendation	would	be	to	expand	the	AE	section	
to	require	confirmation	of	the	presence	or	absence	of	key	AEs	during	transport.	







more	 challenging	 in	 transport	 settings.	 The	 problems	 that	 could	 interfere	 with	 manual	
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Three	studies(7,8,127)	 in	 this	 review	found	a	significantly	 lower	Fi02	 (p<0.001,	 in	all	 three	
studies)	on	arrival	at	destination	compared	with	at	start	of	 transfer.	These	 findings	are	 in	
keeping	with	evidence	that	a	lower	Fi02	is	an	indicator	of	NIV	success.	



















keeping	 with	 accepted	 knowledge	 that	 rising	 C02	 levels	 are	 associated	 with	 worsening	
respiratory	failure	and	increased	likelihood	of	need	for	IPPV.(2,3,141)	
Of	course,	signs	of	clinical	improvement	and	ventilatory	parameters	would	need	to	be	placed	






Mortality	 was	 not	 adequately	 reported	 as	 an	 outcome	 in	 the	 included	 studies.	 This	 is	
unfortunate	 because	 concerns	 have	 been	 raised	 that	 inappropriate	 use	 of	 NIV	 could	
potentially	 delay	 necessary	 IPPV	 and	 thus	 be	 harmful	 to	 patients.	 This	 is	 particularly	 a	
concern	with	HFNC,	which	is	a	newer	and	less	proven	treatment	but	one	that	has	become	
popular	 in	 intensive	 care	 and	 emergency	 settings.	 Hutchings	 et	 al.	 provide	 anecdotal	
evidence	of	inappropriate	HFNC	use	leading	to	emergency	intubation	with	a	need	to	convert	
immediately	to	high	pressure	ventilation	and	even	high-frequency	oscillatory	ventilation.(51)	
An	 adult	 ICU	 study	 found	 that	 those	 receiving	 IPPV	 after	 more	 than	 48	 hours	 of	 HFNC,	
79	
	
compared	 to	 earlier	 intubation,	 had	 significantly	worse	 outcomes	 for	 extubation	 success,	
ventilator	weaning	and	mortality.(87)	
Strengths and Limitations 
Strengths	
The	strengths	of	this	review	include	the	rigorous	systematic	methodology	employed,	with	





To	 the	 author’s	 knowledge,	 this	 is	 the	 first	 systematised	 review	 of	 the	 literature	 on	 NIV	




in	 some	 relevant	 studies	being	missed.	 The	grey	 literature	was	not	 actively	 searched	and	
beyond	searching	the	reference	lists	of	included	studies,	no	other	hand-searching	was	done.	
Again	 this	 could	 have	 resulted	 in	 non-identification	 of	 eligible	 studies.	 This	 study	 did	 not	




for	 this	 review.	 The	 evidence	 included	 comes	 from	 observational	 studies,	 mostly	 with	
retrospective	 record	 review	 design,	 with	 some	 studies	 comparing	 outcomes	 in	 children	
managed	 before	 and	 after	 introduction	 of	 NIV.	 These	 types	 of	 studies	 are	 capable	 of	
providing	only	 low	levels	of	evidence.	Quality	evaluation	of	studies	proved	problematic	as	
the	 available	 information	 precluded	 use	 of	 standard	 tools.	 A	 custom-made	 QA	 tool	 was	
adapted	for	this	purpose,	but	a	weakness	of	this	study	is	that	this	tool	has	not	been	formally	
validated.	






versus	 success,	with	group	sizes	 that	are	 too	small	 to	allow	meaningful	 conclusions	 to	be	
drawn.	


































It	 is	generally	accepted	that	non-invasive	ventilation	 is	not	appropriate	for	use	 in	children	




could	 result	 in	 an	 increased	 burden	 on	 PICU	 and	HCU	beds.	 This	 is	 because	 some	of	 the	






groups	where	no	NIV	 is	 given.(2)	This	 is	a	 conundrum	that	 those	wishing	 to	 conduct	pre-
hospital	 NIV	 research	 may	 face	 imminently.	 Traditional	 oxygen	 administration	 as	 an	
alternative	 to	 NIV,	 in	 pre-hospital	 (or	 hospital)	 NIV	 trials,	 may	 soon	 be	 considered	 an	
unethical	 option.	 Whether	 clinical	 equipoise	 still	 exists	 is	 a	 matter	 that	 clinicians	 and	
researchers	will	need	to	decide	on	in	the	near	future.	
Practical	aspects	of	conducting	research	on	this	topic	
In	 general,	 large-scale	 paediatric	 multi-centre	 randomised-controlled	 trials	 of	 sufficient	
power	 to	 detect	meaningful	 differences	 are	 difficult	 to	 conduct,	 even	when	 they	 involve	
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geography,	 transport	 infrastructure,	 levels	 of	 health-care	 and	 health-system	 referral	
configuration.	 Additionally,	 factors	 relating	 to	 EMS	 structure	 and	 operation	 itself	 could	
influence	results,	such	as	access	to	specialised	or	non-specialised	RT,	unit-based	or	regional	
RT,	 team	 composition,	 vehicle	 configuration,	 available	 equipment,	 level	 of	 training	 and	








Recommendations	 are	 given	 below	 on	 how	 observational	 studies	 of	 NIV	 use	 in	 children	

























of	 children,	 including	 details	 of:	 patient	 variables,	 transport	 details,	 NIV	 equipment,	
interfaces	and	protocols	and	clinical	outcomes	–	see	Table	20.9	This	minimum	data-set	was	









































































































































an	 in-transport	 AE	 rate	 of	 2-4%.	 There	 was	 insufficient	 evidence	 to	 comment	 on	 clinical	








to	 undertake	 prospective	 observational	 studies,	 using	 sound	 methodologies	 and	
comprehensive,	standardised	reporting.		
A	recommended	minimum	data	set	for	standardised	reporting	of	observational	studies,	of	
NIV	 use	 in	 children	 during	 transport,	 is	 suggested.	 It	 is	 recommended	 that	 transport	
databases	and	registries,	are	expanded	to	include	details	of	NIV	equipment,	interfaces	and	
























































































































































































































































































































































































































































being	 capable	 of	 providing	 level	 4	 evidence,	 which	 is	 the	 weakest	 form	 of	 study-based	
evidence;	 only	 ‘mechanistic	 reasoning’	 qualifies	 for	 a	 lower	 rating	 (level	 5).(149)	Another	
classification,	by	Akobeng	rates	systematic	reviews	as	the	highest	level	of	evidence	followed	




Tools	appropriate	 for	assessing	 the	quality	of	evidence	 from	this	study	design	 include	the	
Cochrane	Risk	of	Bias	tool(120),	the	Jadad	scale(151)	and	the	Schulz	system.(152)	
QA	tools	for	non-randomised	studies	of	interventions	










designs.(154–156)	 The	 Enhancing	 the	 QUAlity	 and	 Transparency	 Of	 health	 Research	
(EQUATOR)	network	has	a	library	of	QA	tools	and	resources	for	a	variety	of	study	types.(157)	






reporting	QA	checklists	 for	observational	 studies	 in	healthcare:	10	 created	 specifically	 for	
case-series	studies	and	26	which	assessed	this	study	design	as	well	as	other	designs.(124)	
They	collated	criteria	from	five	of	these	studies	that	met	their	quality	inclusion	criteria	into	a	
30-item	 tool.	 A	 four-round	 Delphi	 process	 was	 conducted	 and	 consensus	 reached	 on	 18	
items,	 which	 form	 a	 new	 QA	 tool	 for	 case-series.	 This	 tool	 was	 then	 validated	 by	 three	
independent	reviewers	on	13	case-series	studies.(124)	
The	authors	are	clear	in	their	discussion	and	conclusion	that	the	tool	they	have	developed	is	
a	 guide	 and	 should	 be	 modified	 by	 systematic	 reviewers	 according	 to	 the	 criteria	 most	






observational	 study	QA	 tool	 for	use	 in	 studies	of	NIV	during	 transport	 	 (Appendix	C).	The	





Appendix B: Quality Appraisal Tool for Case-
Series Studies 

































Appendix C: Adapted Quality Appraisal Tool for Observational Studies of 









Criterion	 Yes	1	 PR	0.5	 No	0	
1	 Is	the	hypothesis/aim/objective	of	the	study	clearly	stated	in	the	abstract,	introduction	or	methods	section?		 	 	 	
2	 Are	the	characteristics	of	the	participants	included	in	the	study	described?		 	 	 	
3	 Are	the	eligibility	criteria	(inclusion	and	exclusion	criteria)	to	entry	the	study	explicit	and	appropriate?		 	 	 	
4	 Were	participants	recruited	consecutively?		 	 	 	
5*	 Was	the	make-up	of	the	transport	team	adequately	described?	 	 	 	
6*	 Were	transport	distances	&/or	durations	described?	 	 	 	
7*	 Were	modes	of	transport	described?	(i.e.	road,	air:	rotary/fixed	wing)	 	 	 	
8*	 Was	the	method	of	NIV	generation	clearly	described	in	the	study?	(Device	details,	manufacturer,	model	etc.)	 	 	 	
9*	 Was	the	type	of	NIV	interface	used	described?	(nasal/NP	prongs,	mask,	helmet	etc.)	 	 	 	
10*	 Is	there	adequate	description	of	the	NIV	protocols	used?	(indications,	contraindications,	pressure/flow	etc.)	 	 	 	
11#	 Were	additional	interventions	(co-	interventions)	clearly	reported	in	the	study?		 	 	 	




14#	 Are	adverse	events	reported?		 	 	 	
15#	 Was	there	any	follow	up	after	the	immediate	transport	period?	 	 	 	
16*	 No	new	results	are	reported	in	the	discussion	section	 	 	 	
17	 Were	the	statistical	tests	used	to	assess	the	relevant	outcomes	appropriate?		 	 	 	
18	 Does	the	study	provide	estimates	of	the	random	variability	in	the	data	analysis	of	relevant	outcomes?		 	 	 	
19	 Are	the	conclusions	of	this	study	supported	by	the	results?	 	 	 	
20#	 Are	both	competing	interest	and	source	of	support	for	the	study	reported?		 	 	 	
102	
	
Appendix D: Details of Studies Used in Clinical Effectiveness of Non-





	 Subramaniam(41)	 Ferguson(90)	 Lemyre(91)	 Wilkinson(45)	 Kotecha(67)	























































































































































































































































































































































































































































































Appendix E: PubMed Search Terms 
Search	terms	used	in	PubMed	search	
(((((((((acute[All	Fields]	AND	respiratory[All	Fields]	AND	distress[All	Fields])	OR	(non[All	Fields]	





OR	 ‘intermittent	 positive-pressure	 ventilation’[All	 Fields]	 OR	 (‘positive’[All	 Fields]	 AND	
‘pressure’[All	 Fields]	 AND	 ‘ventilation’[All	 Fields]))))	 OR	 (‘continuous	 positive	 airway	
pressure’[MeSH	Terms]	OR	(‘continuous’[All	Fields]	AND	‘positive’[All	Fields]	AND	‘airway’[All	
Fields]	 AND	 ‘pressure’[All	 Fields])	 OR	 ‘continuous	 positive	 airway	 pressure’[All	 Fields]	 OR	
(‘nasal’[All	 Fields]	 AND	 ‘continuous’[All	 Fields]	 AND	 ‘positive’[All	 Fields]	 AND	 ‘airway’[All	
Fields]	AND	‘pressure’[All	Fields])	OR	‘nasal	continuous	positive	airway	pressure’[All	Fields]))	
OR	(high[All	Fields]	AND	flow[All	Fields]	AND	(‘cannula’[MeSH	Terms]	OR	‘cannula’[All	Fields]	
OR	 (‘nasal’[All	 Fields]	 AND	 ‘cannula’[All	 Fields])	 OR	 ‘nasal	 cannula’[All	 Fields])))	 OR	
(‘noninvasive	 ventilation’[MeSH	 Terms]	 OR	 (‘noninvasive’[All	 Fields]	 AND	 ‘ventilation’[All	
Fields])	OR	‘noninvasive	ventilation’[All	Fields]	OR	(‘non’[All	Fields]	AND	‘invasive’[All	Fields]	
AND	 ‘ventilation’[All	 Fields])	 OR	 ‘non	 invasive	 ventilation’[All	 Fields]))	 OR	 ‘Noninvasive	
Ventilation’[Mesh])	 OR	 ‘Continuous	 Positive	 Airway	 Pressure’[Mesh])	 OR	 ‘Acute	 Chest	
Syndrome’[Mesh])	AND	((((((((‘infant’[MeSH	Terms]	OR	‘infant’[All	Fields])	OR	(‘child’[MeSH	
Terms]	 OR	 ‘child’[All	 Fields]))	 OR	 ‘Child’[Mesh])	 OR	 ‘Infant’[Mesh])	 OR	 (‘infant,	
newborn’[MeSH	 Terms]	 OR	 (‘infant’[All	 Fields]	 AND	 ‘newborn’[All	 Fields])	 OR	 ‘newborn	
infant’[All	 Fields]	 OR	 ‘neonate’[All	 Fields]))	 OR	 ‘Infant,	 Newborn’[Mesh])	 OR	
(‘pediatrics’[MeSH	 Terms]	 OR	 ‘pediatrics’[All	 Fields]	 OR	 ‘pediatric’[All	 Fields]))	 OR	
‘Pediatrics’[Mesh]))	 AND	 (((((((((((‘Child,	 Hospitalized’[Mesh]	 OR	 ‘Intensive	 Care	
Units’[Mesh])	 OR	 ‘Intensive	 Care	 Units,	 Neonatal’[Mesh])	 OR	 ‘Emergency	 Medical	








OR	 (‘intensive’[All	 Fields]	 AND	 ‘care’[All	 Fields]	 AND	 ‘units’[All	 Fields]	 AND	 ‘neonatal’[All	
Fields])	 OR	 ‘neonatal	 intensive	 care	 units’[All	 Fields]	 OR	 (‘neonatal’[All	 Fields]	 AND	
‘intensive’[All	 Fields]	AND	 ‘care’[All	 Fields]	AND	 ‘units’[All	 Fields])))	OR	 (‘transportation	of	
patients’[MeSH	 Terms]	 OR	 (‘transportation’[All	 Fields]	 AND	 ‘patients’[All	 Fields])	 OR	
‘transportation	 of	 patients’[All	 Fields]	 OR	 (‘patient’[All	 Fields]	 AND	 ‘transportation’[All	
Fields])	 OR	 ‘patient	 transportation’[All	 Fields]))	 OR	 (‘emergency	 medical	 services’[MeSH	
Terms]	OR	 (‘emergency’[All	 Fields]	AND	 ‘medical’[All	 Fields]	AND	 ‘services’[All	 Fields])	OR	
‘emergency	medical	services’[All	Fields]))	OR	((‘pediatrics’[MeSH	Terms]	OR	‘pediatrics’[All	
Fields]	 OR	 ‘pediatric’[All	 Fields])	 AND	 (‘emergency	 medical	 services’[MeSH	 Terms]	 OR	
(‘emergency’[All	Fields]	AND	‘medical’[All	Fields]	AND	‘services’[All	Fields])	OR	‘emergency	


























































































25. BVM	during	Transport	 	 	
26. CPR	during	Transport	 	 	
27. Apnoea	during	Transport	 	 	
28. Desaturation	during	Transport	 	 	
29. Bradycardia	during	Transport	 	 	







































	 	 	 	 	 	 	 	 	 	 	
	 	 	 	 	 	 	 	 	 	 	
	 	 	
	
	
	
	
	
	
	
